1. Home
  2. TTC vs EXEL Comparison

TTC vs EXEL Comparison

Compare TTC & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTC
  • EXEL
  • Stock Information
  • Founded
  • TTC 1914
  • EXEL 1994
  • Country
  • TTC United States
  • EXEL United States
  • Employees
  • TTC N/A
  • EXEL N/A
  • Industry
  • TTC Tools/Hardware
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TTC Consumer Discretionary
  • EXEL Health Care
  • Exchange
  • TTC Nasdaq
  • EXEL Nasdaq
  • Market Cap
  • TTC 9.4B
  • EXEL 10.0B
  • IPO Year
  • TTC N/A
  • EXEL 2000
  • Fundamental
  • Price
  • TTC $83.08
  • EXEL $34.49
  • Analyst Decision
  • TTC Hold
  • EXEL Buy
  • Analyst Count
  • TTC 3
  • EXEL 17
  • Target Price
  • TTC $93.33
  • EXEL $32.18
  • AVG Volume (30 Days)
  • TTC 611.3K
  • EXEL 1.7M
  • Earning Date
  • TTC 12-18-2024
  • EXEL 02-04-2025
  • Dividend Yield
  • TTC 1.69%
  • EXEL N/A
  • EPS Growth
  • TTC 6.40
  • EXEL 441.02
  • EPS
  • TTC 3.81
  • EXEL 1.55
  • Revenue
  • TTC $4,491,000,000.00
  • EXEL $2,081,598,000.00
  • Revenue This Year
  • TTC $1.97
  • EXEL $20.59
  • Revenue Next Year
  • TTC $4.05
  • EXEL $1.50
  • P/E Ratio
  • TTC $22.39
  • EXEL $22.41
  • Revenue Growth
  • TTC N/A
  • EXEL 17.31
  • 52 Week Low
  • TTC $77.15
  • EXEL $19.20
  • 52 Week High
  • TTC $102.00
  • EXEL $36.97
  • Technical
  • Relative Strength Index (RSI)
  • TTC 39.55
  • EXEL 51.61
  • Support Level
  • TTC $85.86
  • EXEL $34.30
  • Resistance Level
  • TTC $89.50
  • EXEL $36.22
  • Average True Range (ATR)
  • TTC 1.77
  • EXEL 0.75
  • MACD
  • TTC -0.39
  • EXEL -0.29
  • Stochastic Oscillator
  • TTC 24.72
  • EXEL 25.09

About TTC Toro Company (The)

The Toro Co manufactures turf maintenance and landscaping equipment. The company produces reel and rotary riding products, trim cutting and walking mowers, greens rollers, turf sprayer equipment, underground irrigation systems, heavy-duty walk-behind mowers, and sprinkler systems used for professional turf and landscape maintenance and construction. Its products are marketed through a network of distributors and dealers to predominantly professional users maintaining turfs and sports fields such as golf courses. Its operating segments are Professional which generates a substantial part of its revenue, and Residential segment. The company also produces snow plowers and ice management products. Its key revenue generating market is the United States.

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: